Life AI Net
홈
아카이브
계산기
디렉토리
뉴스레터
로그인
한국어
English
简体中文
Deutsch
Français
Español
日本語
한국어
العربية
Auto
홈
아카이브
계산기
디렉토리
뉴스레터
English
简体中文
Deutsch
Français
Español
日本語
한국어
العربية
Auto
로그인
홈
아카이브
계산기
디렉토리
More
실시간
10x Genomics Blog
Why 10x Genomics (TXG) Stock Is Down Today - Yahoo Finance
10x Genomics Blog
10x Genomics, Harvard Target Element’s Multiomics Platform in Patent Lawsuit - Genetic Engineering and Biotechnology News
10x Genomics News
10x Genomics, Harvard Target Element’s Multiomics Platform in Patent Lawsuit - Genetic Engineering and Biotechnology News
Science Daily Biotech
A rare cancer-fighting plant compound has been decoded
Eli Lilly
Eli Lilly Clinical Trial Shows Its Obesity Drugs Can Cause Weight Loss And Help Maintain It - Stocktwits
Endpoints News
Lilly points to low-dose Zepbound and Foundayo as weight loss maintenance options
Illumina
The Bull Case For Illumina (ILMN) Could Change Following Upgraded 2026 Outlook And Major Buyback - Learn Why - simplywall.st
Siemens Healthineers
A Look At Siemens Healthineers (XTRA:SHL) Valuation After New HKSH Photon‑Counting CT Partnership - simplywall.st
LabCorp
Labcorp and Epic Expand Collaboration for Lab Test Ordering - Clinical Lab Products
FierceBiotech
FDA Commissioner Marty Makary to resign, capping turbulent tenure: report
FierceBiotech
Kyverna begins rolling submission for autoimmune CAR-T as FDA requests more natural history analysis
Eli Lilly
Eli Lilly Price Prediction: This Is Where The Stock Will End This Year - 24/7 Wall St.
10x Genomics Blog
Why 10x Genomics (TXG) Stock Is Down Today - Yahoo Finance
10x Genomics Blog
10x Genomics, Harvard Target Element’s Multiomics Platform in Patent Lawsuit - Genetic Engineering and Biotechnology News
10x Genomics News
10x Genomics, Harvard Target Element’s Multiomics Platform in Patent Lawsuit - Genetic Engineering and Biotechnology News
Science Daily Biotech
A rare cancer-fighting plant compound has been decoded
Eli Lilly
Eli Lilly Clinical Trial Shows Its Obesity Drugs Can Cause Weight Loss And Help Maintain It - Stocktwits
Endpoints News
Lilly points to low-dose Zepbound and Foundayo as weight loss maintenance options
Illumina
The Bull Case For Illumina (ILMN) Could Change Following Upgraded 2026 Outlook And Major Buyback - Learn Why - simplywall.st
Siemens Healthineers
A Look At Siemens Healthineers (XTRA:SHL) Valuation After New HKSH Photon‑Counting CT Partnership - simplywall.st
LabCorp
Labcorp and Epic Expand Collaboration for Lab Test Ordering - Clinical Lab Products
FierceBiotech
FDA Commissioner Marty Makary to resign, capping turbulent tenure: report
FierceBiotech
Kyverna begins rolling submission for autoimmune CAR-T as FDA requests more natural history analysis
Eli Lilly
Eli Lilly Price Prediction: This Is Where The Stock Will End This Year - 24/7 Wall St.
아카이브
이 기사는 아카이브에서 찾을 수 없습니다.